Freenome has developed a tech platform that merges genomics research and computational expertise to dynamically collect genetic material floating in the blood (cell-free) derived from cells in the body to develop early detection tests for cancer.
Company (Alive / Active)
2627 Hanover Street
Palo Alto, 94304
California, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)